ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
European Respiratory Journal · 2026-01 · 67 (1) · 2402533
DOI: 10.1183/13993003.02533-2024 ↗Kurz gefasst
Leitlinie in der Zeitschrift European Respiratory Journal, online erschienen am 04.09.2025. Verfasst von Katerina M Antoniou und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Greece. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Connective Tissue Diseases. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 341 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Interstitial lung disease (ILD) is a frequent manifestation of connective tissue diseases (CTDs) and is associated with high morbidity and mortality. Clinical practice guidelines to standardise screening, diagnosis, treatment and follow-up for CTD-ILD are of high importance for optimised patient care.
Methods
A European Respiratory Society and European Alliance of Associations for Rheumatology task force committee, composed of pulmonologists, rheumatologists, pathologists, radiologists, methodologists and patient representatives, developed recommendations based on PICO (Patients, Intervention, Comparison, Outcomes) questions with grading of the evidence according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) methodology and complementary narrative questions agreed on by both societies. For both PICO and narrative questions, the Evidence to Decision framework was used to formulate the recommendations.
Results
The task force committee concluded with recommendations for 25 PICO and 28 narrative questions, regarding ILD in the context of systemic sclerosis, rheumatoid arthritis (RA), idiopathic inflammatory myopathies, Sjögren disease (SjD), systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD). In four narrative questions, regarding screening and assessment of risk for ILD progression in MCTD, SjD and SLE and one PICO question regarding pirfenidone in CTD-ILD other than RA-ILD, the task force had insufficient evidence to support recommendations. Screening, diagnostic, monitoring and treatment algorithms were developed based on the recommendations and usual clinical practice.
Conclusions
We provide practical guidance by evidence-based recommendations to clinicians for each of the CTDs. In many cases there is low certainty or absence of evidence and we encourage further research to fill these gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Respiratory Medicine, Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Greece.
- Equally contributing authors.
- Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Internal Medicine and Rheumatology Department, Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Centre for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
ORCID-Profile: Catharina C Moor, Nikoleta Bizymi, Ilaria Galetti, Yannick Allanore, Philippe Dieudé, Vincent Cottin, Aurelie Fabre, Ingrid E Lundberg, Venerino Poletti, Britta Maurer, Mary E Strek, Paul Studenic, Jibril Mohammed, Bruno Crestani, Anna-Maria Hoffmann-Vold
Zitieren
APA
Antoniou, K. M., Distler, O., Gheorghiu, A. M., Moor, C. C., Vikse, J., Bizymi, N., Galetti, I., Brown, G., Bargagli, E., Allanore, Y., Corte, T. J., Dieudé, P., Cottin, V., Fisher, B. A., Fabre, A., Giles, J. T., Kreuter, M., Lundberg, I. E., Poletti, V., …, & Hoffmann-Vold, A. M. (2026). ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. European Respiratory Journal, 67(1), 2402533. https://doi.org/10.1183/13993003.02533-2024
Vancouver
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, et al. ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. European Respiratory Journal. 2026;67(1):2402533. doi:10.1183/13993003.02533-2024
BibTeX
@article{Antoniou2026,
author = {Antoniou, Katerina M and Distler, Oliver and Gheorghiu, Ana-Maria and Moor, Catharina C and Vikse, Jens and Bizymi, Nikoleta and Galetti, Ilaria and Brown, Graham and Bargagli, Elena and Allanore, Yannick and Corte, Tamera J and Dieudé, Philippe and Cottin, Vincent and Fisher, Benjamin A and Fabre, Aurelie and Giles, Jon T and Kreuter, Michael and Lundberg, Ingrid E and Poletti, Venerino and Maurer, Britta and Renzoni, Elisabetta A and Müller-Ladner, Ulf and Strek, Mary E and Sverzellati, Nicola and Studenic, Paul and Mohammed, Jibril and Nagavci, Blin and Stamm, Tanja and Tonia, Thomy and Crestani, Bruno and Hoffmann-Vold, Anna-Maria},
title = {ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {1},
pages = {2402533},
doi = {10.1183/13993003.02533-2024}
}
EUVIMED